NCT05116969View on ClinicalTrials.gov

A Phase 1 Study of PTX-35 in Healthy Volunteers

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

November 24, 2021

Primary Completion Date

November 29, 2022

Study Completion Date

November 29, 2022

Conditions

Healthy Volunteer

Interventions

DRUG

PTX-35

PTX-35 is a humanized, affinity matured, IgG2 monoclonal antibody

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Heat Biologics

INDUSTRY